CSL Behring - Company & Market Research Reports

Home /
Companies /
CSL Behring

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

REFINE BY

KEYWORD

Hereditary Angioedema Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
120 Pages
Global

From

€4471EUR$4,500USD£3,717GBP

Angioedema Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
120 Pages
Global

From

€4471EUR$4,500USD£3,717GBP

U.S. Vaccines, Skin Replacement Products and Biologicals Manufacturing: Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030

 Report
September 2024
103 Pages
United States

From

€2479EUR$2,495USD£2,061GBP

Fibrin Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2023
85 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

Fibrinogen Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2023
89 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Factor IX Deficiency Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2023
78 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World

 Report
November 2023
63 Pages
Global

€8714EUR$9,078USD£7,000GBP

Novel Oral Anti Coagulant Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
July 2023
133 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

Clotting Factor Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
June 2023
88 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

Fibrinogen Concentrates Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

 Report
May 2023
85 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

Coagulation Factor IX Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

 Report
March 2023
102 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

Fibrinogen Concentrate Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
January 2022
117 Pages
Global

From

€4719EUR$4,750USD£3,923GBP

The Corporate Reputation of Pharma in 2021 - the Patient Perspective - Rare Disease Edition - The Views of 303 Rare-Disease Patient Groups

 Report
October 2022
58 Pages
Global

€9959EUR$10,375USD£8,000GBP

Hemophilia A - Market Insight, Epidemiology And Market Forecast - 2032

 Report
September 2022
283 Pages
Global

From

€5216EUR$5,250USD£4,336GBP

€7451EUR$7,500USD£6,195GBP

Investigation Report on China's Human Serum Albumin Market 2021-2025

 Report
April 2021
China

From

€2583EUR$2,600USD£2,148GBP

Subcutaneous Infusion System Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
March 2024
117 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

Small Form Factor Subcutaneous Infusion System Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
March 2024
123 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

Hemophilia B - Market Insight, Epidemiology and Market Forecast -2032

 Report
January 2022
200 Pages
Global

From

€5216EUR$5,250USD£4,336GBP

€7451EUR$7,500USD£6,195GBP

Plasma Protease C1-inhibitor Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

 Report
January 2022
110 Pages
Global

From

€4719EUR$4,750USD£3,923GBP

HAE Therapies Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
85 Pages
Global

From

€3500EUR$3,774USD£3,012GBP

290 Results (Page 6 of 15)
- 1
- 4
- 5
- 6
- 7
- 8

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.